Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
For more information, read the full details of GLP-1 Bridge by clicking here.
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (sustain 1): A double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3A trial
Fielding, R., Riede, L., Lugo, J
Among adults diagnosed with type 2 diabetes, historically the primary prescribing indication, GLP-1 medication use reached 26.5% in 2024
While they offer promising benefits, they also come with considerable costs and potential drawbacks
Nien HC, Hsu SJ, Su TH et al (2017) High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments
US$ 26.74
US$ 23.92
US$ 28.18
